Harvard Bioscience, Inc.
Hedge Funds Holdings
Last updated:
Harvard Bioscience, Inc.‘s stocks are currently a part of 67 hedge funds’ portfolios, which represents 66.44% of the total amount of its stocks outstanding. This makes up a total of 28.27M shares of Harvard Bioscience, Inc.. Compared to the previous quarter, the number fell by -4.68% or -1.38M shares fewer. As for the holding position changes, 34.33% (23) of current hedge fund investors increased the number of shares held, 43.28% (29) of current holders sold a part of the shares held, and 25.37% (17) closed the holdings completely. 4 hedge funds are new holders of Harvard Bioscience, Inc. stock in Q3 2022, it is 5.97% of total holders.
Hedge funds holding Harvard Bioscience (Q4 2017 – Q3 2022)
| Q4 2017 | 55 |
|---|---|
| Q1 2018 | 71 |
| Q2 2018 | 79 |
| Q3 2018 | 92 |
| Q4 2018 | 79 |
| Q1 2019 | 86 |
| Q2 2019 | 75 |
| Q3 2019 | 66 |
| Q4 2019 | 66 |
| Q1 2020 | 59 |
| Q2 2020 | 85 |
| Q3 2020 | 83 |
| Q4 2020 | 80 |
| Q1 2021 | 87 |
| Q2 2021 | 98 |
| Q3 2021 | 98 |
| Q4 2021 | 102 |
| Q1 2022 | 96 |
| Q2 2022 | 86 |
| Q3 2022 | 67 |
Hedge funds changes in Harvard Bioscience positions (Q4 2017 – Q3 2022)
| Q4 2017 | 6 | 19 | 18 | 4 | 8 |
|---|---|---|---|---|---|
| Q1 2018 | 20 | 22 | 17 | 4 | 8 |
| Q2 2018 | 16 | 29 | 26 | 8 | 0 |
| Q3 2018 | 20 | 36 | 22 | 6 | 8 |
| Q4 2018 | 4 | 30 | 32 | 18 | -5 |
| Q1 2019 | 12 | 22 | 38 | 5 | 9 |
| Q2 2019 | 11 | 28 | 27 | 20 | -11 |
| Q3 2019 | 9 | 20 | 22 | 18 | -3 |
| Q4 2019 | 7 | 15 | 23 | 7 | 14 |
| Q1 2020 | 5 | 20 | 22 | 11 | 1 |
| Q2 2020 | 32 | 30 | 12 | 5 | 6 |
| Q3 2020 | 7 | 27 | 35 | 9 | 5 |
| Q4 2020 | 4 | 30 | 27 | 6 | 13 |
| Q1 2021 | 15 | 27 | 32 | 8 | 5 |
| Q2 2021 | 22 | 35 | 31 | 10 | 0 |
| Q3 2021 | 10 | 38 | 34 | 10 | 6 |
| Q4 2021 | 15 | 34 | 34 | 10 | 9 |
| Q1 2022 | 8 | 27 | 39 | 13 | 9 |
| Q2 2022 | 19 | 29 | 29 | 27 | -18 |
| Q3 2022 | 4 | 23 | 29 | 17 | -6 |
Hedge funds changes in Harvard Bioscience stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 2,000 | 0 |
| Q2 2019 | 3,000 | 0 |
| Q3 2019 | 18,000 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 4,000 | 0 |
| Q1 2021 | 10,000 | 5,000 |
| Q2 2021 | 35,000 | 18,000 |
| Q3 2021 | 112,000 | 18,000 |
| Q4 2021 | 21,000 | 34,000 |
| Q1 2022 | 32,000 | 4,000 |
| Q2 2022 | 1,000 | 0 |
| Q3 2022 | 0 | 0 |